Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Moachun Qin"'
Autor:
Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Devin Dressman, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo, Moachun Qin, Yirong Wang, Felicia L. Lenzo, Angela Omilian, Wiam Bshara, Matthew Zibelman, Pooja Ghatalia, Konstantin Dragnev, Keisuke Shirai, Katherine G. Madden, Laura J. Tafe, Neel Shah, Deepa Kasuganti, Luis de la Cruz-Merino, Isabel Araujo, Yvonne Saenger, Margaret Bogardus, Miguel Villalona-Calero, Zuanel Diaz, Roger Day, Marcia Eisenberg, Steven M. Anderson, Igor Puzanov, Lorenzo Galluzzi, Mark Gardner, Marc S. Ernstoff
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-12 (2018)
Abstract Background Immune checkpoint inhibitors (ICIs) have changed the clinical management of melanoma. However, not all patients respond, and current biomarkers including PD-L1 and mutational burden show incomplete predictive performance. The clin
Externí odkaz:
https://doaj.org/article/956c5246c411433fb1a686b13fb6565c
Autor:
Saby George, Antonios Papanicolau-Sengos, Felicia L. Lenzo, Jeffrey M. Conroy, Mary Nesline, Sarabjot Pabla, Sean T. Glenn, Blake Burgher, Jonathan Andreas, Vincent Giamo, Moachun Qin, Yirong Wang, Lorenzo Galluzzi, Carl Morrison
Publikováno v:
OncoImmunology, Vol 7, Iss 12 (2018)
We report the immunological profile of a patient with upper-tract urothelial carcinoma experiencing stable disease on pembrolizumab for 20 months. The tumor exhibited extensive infiltration by CD8+ cytotoxic T lymphocytes, low-to-moderate mutational
Externí odkaz:
https://doaj.org/article/d2f010eab60142edba843f3129fc3a12
Autor:
Angela Omilian, Mark Gardner, Fiona Hyland, Wiam Bshara, Jeffrey M. Conroy, Antonios Papanicolau-Sengos, Sean T. Glenn, Vincent Giamo, Blake Burgher, Ji He, Moachun Qin, Mary Nesline, Carl Morrison, Igor Puzanov, Felicia L. Lenzo, Lorenzo Galluzzi, Jonathan Andreas, Sarabjot Pabla, Marc S. Ernstoff
Publikováno v:
The Journal of Molecular Diagnostics. 20:95-109
We have developed a next-generation sequencing assay to quantify biomarkers of the host immune response in formalin-fixed, paraffin-embedded (FFPE) tumor specimens. This assay aims to provide clinicians with a comprehensive characterization of the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a2b87896fd954f878d046792a703277
https://doi.org/10.1016/j.jmoldx.2017.10.001
https://doi.org/10.1016/j.jmoldx.2017.10.001
Autor:
Moachun Qin, Igor Puzanov, Yvonne M. Saenger, Blake Burgher, Roger Day, Isabel Araujo, Pooja Ghatalia, Jeffrey M. Conroy, Konstantin H. Dragnev, Sean T. Glenn, Neel Shah, Matthew Zibelman, Lorenzo Galluzzi, Antonios Papanicolau-Sengos, Mark Gardner, Devin Dressman, Angela Omilian, Katherine G. Madden, Deepa Kasuganti, Jonathan Andreas, Vincent Giamo, Margaret Bogardus, Luis de la Cruz-Merino, Keisuke Shirai, Carl Morrison, Steven M. Anderson, Laura J. Tafe, Wiam Bshara, Marcia Eisenberg, Marc S. Ernstoff, Zuanel Diaz, Yirong Wang, Sarabjot Pabla, Mary Nesline, Felicia L. Lenzo, Miguel A. Villalona-Calero
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-12 (2018)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Immune checkpoint inhibitors (ICIs) have changed the clinical management of melanoma. However, not all patients respond, and current biomarkers including PD-L1 and mutational burden show incomplete predictive performance. The clinical vali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ddecd34a3dc2144d7aed20e121cadea
https://hdl.handle.net/10668/12439
https://hdl.handle.net/10668/12439
Autor:
Jonathan Andreas, Sarabjot Pabla, Saby George, Carl Morrison, Lorenzo Galluzzi, Sean T. Glenn, Blake Burgher, Jeffrey M. Conroy, Antonios Papanicolau-Sengos, Yirong Wang, Moachun Qin, Vincent Giamo, Mary Nesline, Felicia L. Lenzo
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 7, Iss 12 (2018)
OncoImmunology, Vol 7, Iss 12 (2018)
We report the immunological profile of a patient with upper-tract urothelial carcinoma experiencing stable disease on pembrolizumab for 20 months. The tumor exhibited extensive infiltration by CD8+ cytotoxic T lymphocytes, low-to-moderate mutational
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c54d552f4cb42444d47c6592b8bb6fe
https://pubmed.ncbi.nlm.nih.gov/30524881
https://pubmed.ncbi.nlm.nih.gov/30524881
Autor:
Morrison, Carl, Sarabjot Pabla, Conroy, Jeffrey, Nesline, Mary, Glenn, Sean, Dressman, Devin, Papanicolau-Sengos, Antonios, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Moachun Qin, Yirong Wang, Lenzo, Felicia, Omilian, Angela, Wiam Bshara, Zibelman, Matthew, Ghatalia, Pooja, Dragnev, Konstantin, Shirai, Keisuke, Madden, Katherine, Tafe, Laura, Shah, Neel, Kasuganti, Deepa, Cruz-Merino, Luis De La, Araujo, Isabel, Saenger, Yvonne, Bogardus, Margaret, Villalona-Calero, Miguel, Zuanel Diaz, Day, Roger, Eisenberg, Marcia, Anderson, Steven, Puzanov, Igor, Galluzzi, Lorenzo, Gardner, Mark, Ernstoff, Marc
Supplementary appendix including additional methods and results. (DOCX 40 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b63caf0dedb997c8deb711558838b52